Silver nanoparticles have been shown to reduce the viability of tumor cell lines from breast (Ulagesan, 2021), lung (Pallavi, 2022), cervical (Barua, 2017), bone (Michalakis, 2021) and leukemia (Guo, 2014) neoplasms. Ferreira (Ferreira, 2020) found silver nanoparticles reduced cell viability in bladder cancer cells.
Castiglioni (Castiglioni, 2025)showed that the cytotoxic effects of silver nanoparticles on T24 cells was dependent on ERK activation and Flamm and Grof (Flamm, 1984) tried to use silver nitrate installation following surgery for bladder tumors.
We have shown that the combination of either colloidal silver or silver nitrate and hydrogen peroxide yields greater cancer cell loss than any of these agents used alone. Choudhary et al (Choudhary, 2011) reported hydrogen peroxide cooperated with oncogenic H-Ras and FK 228 to activate the erk pathway inducing J82 cell death.
We found the combination of silver forms and hydrogen peroxide is augmented by EA in the probable hypoxic environment of these cells (Zhang,2019, Lin 2018). We have done this using concentrations and exposure times previously used (Fletcher, 2015, Shen, 1990). EA has been used with other agents (Nagouney, 1990) but not in bladder cells.
The BSA and FBS used here may have diminished the effects we report here by binding silver (Shahabadi, 2019, Gnanadhas, 2019) .
While the mean levels of glutathione were lower in treated cells we could not verify the reduction was significant due to the low levels of this agent in the J 82 cells. It is possible the levels of glutathione were reduced enough to account for the effects we observed but the effect of EA we report may be due to other properties (Yu,2023) of EA.